CATALYST PHARMACEUTICALS, INC. (10) | Stock Agreements (4)
- Description of the Companys Capital Stock (Filed With SEC on March 16, 2022)
- Description of the Companys Capital Stock (Filed With SEC on March 15, 2021)
- Description of the Companys Capital Stock (Filed With SEC on March 16, 2020)
- Amendment No. 2 to Rights Agreement, dated as of August 28, 2019, between Catalyst Pharmaceuticals, Inc. and Continental Stock Transfer and Trust Company, as Rights Agent (Filed With SEC on August 30, 2019)
